Novartis Pharmaceuticals Corp v. Secretary United States Department of Health, decided by Third Circuit on September 11, 2025, resulted in a defendant win outcome. The Third Circuit affirmed the Distr...
Actavis Laboratories Fl, Inc. v. United States, decided by Federal Circuit on March 21, 2025, resulted in a defendant win outcome. The case concerns the interpretation of the "substantially all" limit...